Behavior, social competence and quality of life in Huntington's disease
Comportamento, competência social e qualidade de vida na doença de Huntington
Caroline Stephanie da Silva; Tâmara Andrade Lindau; Célia Maria Giacheti
Abstract
Purpose: to investigate the behavior, the social competence and the quality of life of subjects with Huntington Disease (HD).
Methods: the sample was constituted of 30 participants, from 33 to 79 years old, divided in two groups: 15 participants in the experimental group (EG), who were previously diagnosed with Huntington Disease and 15 participants in the control group (CG), equally paired according to age and education. The Behavioral Inventory, constituted by the Adult Behavior Checklist and the Quality of Life Questionnaire WHOQOL – 100 were used to assess the caregivers.
Results: the Behavioral Inventory showed statistically significant differences for the EG when compared to the CG, with high scores for internalized factors (anxiety, depression, isolation, somatic complaints), total problems and other problems as thinking, attention and hyperactivity, according to their caregivers opinion. In the Quality of Life Questionnaire the EG presented statistically significant differences when compared to the CG, in all areas (physical, psychological, level of independence, social relationships, environment and religious aspects). In most of the assessed aspects EG presented low average of quality of life, while the CG presented high average.
Conclusion: subjects with HD present behavioral, social competence and quality of life differentiated and altered profile, according to their caregivers, when compared to CG. HD is a limiting, progressive disease that seems to be responsible for the set of behavioral, social competence and quality of life changes reported by their caregivers.
Keywords
Resumo
Objetivo: investigar o comportamento, a competência social e a qualidade de vida de indivíduos com a Doença de Huntington (DH), segundo opinião de seus cuidadores.
Métodos: constituíram a casuística 30 participantes, com faixa etária de 33 a 79 anos, subdivididos em dois grupos: 15 do grupo amostral (GA) diagnosticados previamente com Doença de Huntington e 15 participantes do grupo controle (GC), pareados quanto à faixa etária, gênero e classificação socioeconômica. Para avaliação destes sujeitos foram aplicados, em seus cuidadores, o Inventário Comportamental Adult Behavior Checklist e o Questionário de Qualidade de Vida WHOQOL-100.
Resultados: na avaliação do comportamento e da competência social, os sujeitos do GA apresentaram diferença estatisticamente significante em relação ao GC, segundo opinião dos seus cuidadores, com escores elevados para fatores internalizantes (ansiedade, depressão, isolamento, queixas somáticas), totais de problemas e outros, como problemas do pensamento, atenção e hiperatividade. No questionário de qualidade de vida, para sujeitos com a DH também se evidenciou diferença estatisticamente significante em relação ao grupo controle, em todos os domínios (físico, psicológico, nível de independência, relações sociais, ambiente e aspectos religiosos) e na maioria dos subitens avaliados. O GA, apresentou média baixa de qualidade de vida, enquanto o GC apresentou média alta.
Conclusão: sujeitos com DH possuem um perfil comportamental, de competência social e qualidade de vida diferenciado e com mais alterações, em relação ao GC, segundo os cuidadores. A Doença de Huntington parece ser responsável pelo conjunto de alterações comportamentais, de competência social e de qualidade de vida, relatado pelos cuidadores.
Palavras-chave
Referências
1. OMIM (Online Mendelian Inheritance in Man). Johns Hopkins University; Inc.; 1966-2008. Disponível em: http://www.omim.org/entry/143100
2. Roos ACR. Huntington's disease: a clinical review. Orphanet j. rare dis. 2010;5:1-8.
3. INSTITUTO NACIONAL FRANCÊS DE SAÚDE E INVESTIGAÇÃO MÉDICA. (Coord.). Orphanet: o portal para as doenças raras e os medicamentos orfãos. 2014. Disponível em: <http://www.orphanet/consor/cgi-bin/index.php?lng=PT>.
4. Henley SM, Wild EJ, Hobbs NZ, Frost C, Macmanus DG, Barker RA et al. Whole-brain atrophy as a measure of progression in premanifest and early Huntington's disease. Mov. disord. 2009;24:932-6.
5. AMERICAN PSYCHIATRIC ASSOCIATION. Diagnostic and statistical manual of mental disorders: DSM-V. American Psychiatric Publishing, 2013.
6. Azambuja MJ. Contribuição ao estudo da linguagem em indivíduos com doença de Huntington [dissertação]. São Paulo (SP): Universidade de São Paulo; 2006.
7. Azambuja MJ, Radanovic M, Haddad MS, Adda CC, Barbosa ER, Mansur LL. Language impairment in Huntington's disease. Arq. neuropsiquiatr. 2012;70(6):410-5.
8. Cummings JL. Behavioral and psychiatric symptoms associated with Huntington's disease. Adv. neurolo. 1995;65:179-86.
9. Duijin E, Kingma EM, Mast RC. Psychopathology in Verified Huntington's Disease Gene Carriers. J. neuropsychiatry clin. neurosci. 2007;19:441-8.
10. Thompson JC, Snowden JS, Craufurd D, Neary D. Behavior in Huntington's Disease: Dissociating Cognition-Based and Mood-Based Changes. J. neuropsychiatry clin. neurosci. 2002;14:37-43.
11. Di Maio L, Squitieri F, Napolitano G, Campanella G, Trofatter JA, Conneally PM. Suicide risk in Huntington's disease. J. medical. genet. 1993;30:293-5.
12. Helder DI, Kaptein AA, Van Kempen GM, Van Houwelingen JC, Roos RA. Impact of Huntington's disease on quality of life. Mov. disord. 2001;16(2):325-30.
13. Williams JK, Skirton H, Paulsen JS, Tripp-Reimer T, Jarmon L, Mcgonigal KM, et al. The emotional experiences of family carers in Huntington disease. J. adv. nurs. Epub 2009;65(4):789-98.
14. Banaszkiewicz K, Sitek EJ, Rudzińska M, Sołtan W, Sławek J, Szczudlik A. Huntington's disease from the patient, caregiver and physician's perspectives: three sides of the same coin? J. neural. transm. 2012;119(11):1361-5.
15. Kingma EM, Van Duijn E, Timman R, Mast RC, Roos RA. Behavioural problems in Huntington's disease using the Problem Behaviours Assessment. Gen. hosp. psychiatr. 2008;30(2):155-61.
16. Craufurd D, Thompson JC, Snowden JS. Behavioral changes in Huntington Disease. Neuropsychiatry neuropsychol. behav. neurol. 2001;14(4):219-26.
17. Carlozzi NE, Tulsky DS. Identification of health-related quality of life (HRQOL) issues relevant to individuals with Huntington disease. J. health psychol. 2013;18(2):212-25.
18. Achenbach TM, Rescorla LA. Manual for the ASEBA School-Age Forms & Profiles. Burlington, VT: University of Vermont, Research Center for Children, Youth & Families, 2001
19. WHOQOL Group. WHOQOL User Manual. Programme on mental health, 1998. Disponível em: www.who.int/.../who_qol_user_manual_98.pdf
20. Achenbach TM, Rescorla LA, Maruish ME. The Achenbach System of Empirically Based Assessment (ASEBA) for ages 1.5 to 18 years. In: Maruish ME, editor. The Use of Psychological Testing for Treatment Planning and Outcomes Assessment. New Jersey: Taylor & Francis; 2004. P.179-213.
21. Rosenblatt A. Neuropsychiatry of Huntington's disease. Dialogues clin. neurosci. 2007;9(2):191-7.
22. Paulsen JS, Ready RE, Hamilton JM, Mega M, Cummings J. Neuropsychiatric aspects of Huntington's disease. J. neurol., neurosurg. psychiatry. 2001;71:310–4.
23. Paulsen JS, Nehl C, Hoth KF, Kanz JE, Benjamin M, Conybeare R et al. Depression and stages of Huntington's disease. J. neuropsychiatry clin. neurosci. 2005;17(4):496-502.
24. Reedeker N, Bouwens JA, Giltay EJ, Le Mair SE, Roos RA, Mast RCVD et al. Irritability in Huntington's disease. Psychiatry res. 2012;200(2):813-8.
25. Nimmagadda SR, Agrawal N, Worrall-Davies A, Markova I, Rickards H. Determinants of irritability in Huntington's disease. Acta neuropsychiatr. 2011;23(6):309-14.
26. Aubeeluck AV, Buchanan H, Stupple EJ. All the burden on all the carers': exploring quality of life with family caregivers of Huntington's disease patients. Qual. life res. 2012;21(8):1425-35.
Submetido em:
19/12/2014
Aceito em:
13/02/2015
Facebook
Twitter
LinkedIn
Mendeley
Email